NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.3020
Dollar change
+0.0070
Percentage change
2.37
%
Index- P/E- EPS (ttm)-2.07 Insider Own13.71% Shs Outstand39.04M Perf Week2.03%
Market Cap11.79M Forward P/E- EPS next Y-0.43 Insider Trans-1.03% Shs Float33.69M Perf Month6.83%
Enterprise Value-23.76M PEG- EPS next Q-0.18 Inst Own45.08% Short Float4.41% Perf Quarter-0.98%
Income-79.75M P/S- EPS this Y75.66% Inst Trans14.32% Short Ratio2.65 Perf Half Y-44.28%
Sales0.00M P/B0.32 EPS next Y29.35% ROA-90.12% Short Interest1.48M Perf YTD-48.53%
Book/sh0.96 P/C0.32 EPS next 5Y62.77% ROE-110.70% 52W High3.67 -91.77% Perf Year-87.47%
Cash/sh0.94 P/FCF- EPS past 3/5Y-19.25% -73.94% ROIC-209.74% 52W Low0.22 37.55% Perf 3Y-89.02%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility6.60% 9.65% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM32.23% Oper. Margin- ATR (14)0.03 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.26 Sales Y/Y TTM- Profit Margin- RSI (14)49.44 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio7.26 EPS Q/Q65.92% SMA20-3.98% Beta2.99 Target Price0.40
Payout- Debt/Eq0.03 Sales Q/Q- SMA503.75% Rel Volume0.07 Prev Close0.29
Employees26 LT Debt/Eq0.02 EarningsMay 09 AMC SMA200-30.35% Avg Volume559.56K Price0.30
IPOSep 18, 2020 Option/ShortYes / Yes EPS/Sales Surpr.4.17% - Trades Volume38,037 Change2.37%
Date Action Analyst Rating Change Price Target Change
Sep-19-24Downgrade Mizuho Outperform → Neutral $5 → $0.50
Sep-04-24Downgrade Rodman & Renshaw Buy → Neutral
Sep-04-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-04-24Downgrade BTIG Research Buy → Neutral
Aug-19-24Initiated Rodman & Renshaw Buy $22
Oct-17-22Upgrade JMP Securities Mkt Perform → Mkt Outperform $20
Jul-07-22Initiated Mizuho Buy $6
Jun-23-22Downgrade Stifel Buy → Hold $36 → $5
Jun-23-22Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-23-22Downgrade Jefferies Buy → Hold $32 → $3
May-14-25 11:10AM
May-13-25 11:00AM
May-09-25 04:05PM
Feb-27-25 04:05PM
Dec-06-24 05:30PM
04:50AM Loading…
Nov-08-24 04:50AM
Nov-07-24 04:05PM
Oct-22-24 07:00AM
Sep-17-24 09:00AM
Sep-04-24 11:40AM
11:33AM
08:48AM
Sep-03-24 04:01PM
Aug-23-24 09:40AM
Aug-07-24 09:40AM
04:05PM Loading…
Aug-01-24 04:05PM
Jul-31-24 08:05AM
Jul-10-24 08:51AM
Jul-09-24 07:00AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
May-29-24 07:00AM
May-17-24 05:00PM
May-15-24 10:54PM
04:05PM
May-07-24 09:15AM
May-02-24 07:00AM
Apr-15-24 07:00AM
Apr-11-24 07:00AM
Apr-03-24 07:00AM
07:00AM Loading…
Mar-08-24 07:00AM
Feb-28-24 12:00PM
Feb-22-24 04:05PM
Feb-15-24 02:56PM
Feb-08-24 04:02PM
Jan-08-24 07:00AM
Jan-03-24 07:00AM
Dec-12-23 07:00AM
Dec-05-23 10:25AM
Nov-29-23 07:00AM
Nov-28-23 07:00AM
Nov-15-23 08:15AM
Nov-09-23 04:05PM
Nov-08-23 07:00AM
Oct-05-23 04:30PM
Sep-28-23 07:00AM
Sep-19-23 07:00AM
Sep-08-23 12:00PM
Aug-31-23 09:35AM
Aug-29-23 09:55AM
Aug-10-23 04:05PM
Jul-17-23 07:00AM
Jul-06-23 11:52AM
07:00AM
Jun-08-23 06:08AM
Jun-07-23 08:10AM
May-31-23 07:00AM
May-22-23 07:00AM
May-12-23 11:34AM
May-11-23 04:05PM
12:25PM
May-08-23 07:00AM
Apr-29-23 08:45AM
Apr-25-23 04:01PM
Apr-11-23 07:00AM
Apr-02-23 08:14AM
Mar-28-23 12:00PM
01:00AM
Mar-23-23 04:05PM
Mar-08-23 07:00AM
Mar-06-23 07:00AM
Feb-01-23 07:00AM
Jan-31-23 07:00AM
Jan-28-23 08:00AM
Jan-27-23 10:08AM
Jan-17-23 01:00AM
Jan-05-23 07:00AM
Jan-03-23 06:26AM
Dec-21-22 07:00AM
Dec-09-22 05:34AM
Dec-05-22 07:30AM
Dec-01-22 07:00AM
Nov-29-22 11:00AM
Nov-28-22 07:00AM
Nov-21-22 07:00AM
Nov-16-22 07:00AM
Nov-10-22 04:05PM
Nov-09-22 07:00AM
Nov-07-22 07:00AM
Oct-30-22 08:29AM
Oct-17-22 07:00AM
Sep-16-22 08:14AM
Sep-06-22 03:22PM
07:00AM
Aug-20-22 08:01AM
Aug-15-22 04:05PM
Aug-03-22 11:28AM
Aug-02-22 03:30PM
Jul-25-22 07:00AM
Jul-08-22 04:19PM
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
San Martin JavierCHIEF MEDICAL OFFICERDec 31 '24Option Exercise0.0046,667046,667Jan 03 05:05 PM
San Martin JavierCHIEF MEDICAL OFFICERJan 02 '25Sale0.5610,8266,08335,841Jan 03 05:05 PM
Litton Mark JamesPresident and CEODec 31 '24Option Exercise0.00108,3330267,698Jan 03 05:04 PM
Litton Mark JamesPresident and CEOJan 02 '25Sale0.5625,10714,108242,591Jan 03 05:04 PM
CHURCH KEVINCHIEF SCIENTIFIC OFFICERDec 31 '24Option Exercise0.0036,6670139,271Jan 03 05:03 PM
CHURCH KEVINCHIEF SCIENTIFIC OFFICERJan 02 '25Sale0.568,5104,782130,761Jan 03 05:03 PM
Renninger RobertVP of FinanceDec 31 '24Option Exercise0.0012,359092,605Jan 03 05:01 PM
Renninger RobertVP of FinanceJan 02 '25Sale0.562,8811,61989,724Jan 03 05:01 PM
Worthington MarkGeneral Counsel and CCODec 31 '24Option Exercise0.0036,667092,245Jan 03 05:00 PM
Worthington MarkGeneral Counsel and CCOJan 02 '25Sale0.568,5104,78283,735Jan 03 05:00 PM
Javier San MartinOfficerJan 02 '25Proposed Sale0.5610,8266,083Jan 02 08:06 PM
Mark James LittonOfficerJan 02 '25Proposed Sale0.5625,10714,108Jan 02 08:05 PM
Mark WorthingtonOfficerJan 02 '25Proposed Sale0.568,5104,782Jan 02 08:04 PM
Kevin ChurchOfficerJan 02 '25Proposed Sale0.568,5104,782Jan 02 08:02 PM
Mark James LittonOfficerSep 05 '24Proposed Sale0.005,0321Sep 05 07:53 PM
Gengos AndrewCFO and Chief Business OfficerSep 05 '24Sale0.571,27272097,532Sep 05 07:51 PM
Lenington RachelCOO and CDOSep 05 '24Sale0.572,5251,42920,870Sep 05 07:50 PM
CHURCH KEVINCHIEF SCIENTIFIC OFFICERSep 05 '24Sale0.572,5251,42992,684Sep 05 07:49 PM
Worthington MarkGENERAL COUNSELSep 05 '24Sale0.572,5251,42951,927Sep 05 07:48 PM
Litton Mark JamesPresident and CEOSep 05 '24Sale0.575,0322,848159,365Sep 05 07:47 PM